Mirum Pharmaceuticals, Inc.
Public company- Headquarters
- FOSTER CITY, California
- Ticker
- MIRM
- CIK
- 0001759425
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CMORob Myers, M.D. | Sep 8, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- ACADIA PHARMACEUTICALS INC
Executive Vice President, Head of Research and Development departs: Elizabeth H.Z. Thompson, Ph.D.
- KYNTRA BIO, INC.
Class III director appointed: Andrew E. Singer, MBA
- BIOMARIN PHARMACEUTICAL INC
WARN notice: Novato, CA
- CORCEPT THERAPEUTICS INC
President of Corcept Endocrinology departs: Sean Maduck
- Executive appointment
CMO appointed: Rob Myers, M.D.
Rob Myers, M.D. was named Chief Medical Officer of Mirum Pharmaceuticals, Inc., effective September 21, 2026. Rob Myers, M.D. succeeds Joanne Quan, M.D.. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 8, 2026Role: Chief Medical Officer
Only one public record so far. We add events as soon as a new filing lands; watch Mirum Pharmaceuticals, Inc. to get them in your digest.
Last verified Nov 8, 2026